{"id":2568,"date":"2023-12-25T17:02:06","date_gmt":"2023-12-25T14:02:06","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=2568"},"modified":"2023-12-25T17:13:12","modified_gmt":"2023-12-25T14:13:12","slug":"humanis-altin-havan-odulune-layik-goruldu","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=2568","title":{"rendered":"Humanis, Alt\u0131n Havan \u00d6d\u00fcl\u00fc\u2019ne Lay\u0131k G\u00f6r\u00fcld\u00fc"},"content":{"rendered":"\n<p><strong>\u0130nsan odakl\u0131 sa\u011fl\u0131k felsefesini benimseyen Humanis, 13. Alt\u0131n Havan \u00d6d\u00fclleri\u2019nde nadir hastal\u0131klardan biri olan serebrotendin\u00f6z ksantomatozisin tedavisine y\u00f6nelik sundu\u011fu \u00fcr\u00fcn\u00fc ile \u2018\u00dcr\u00fcn \u00d6d\u00fcl\u00fc\u2019ne l\u00e2y\u0131k g\u00f6r\u00fcld\u00fc.<\/strong><\/p>\n\n\n\n<p>T\u00fcrk ila\u00e7 sekt\u00f6r\u00fcn\u00fcn en h\u0131zl\u0131 b\u00fcy\u00fcyen \u015firketlerinden biri olan Humanis, g\u00fcvenilir ve etkin sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri \u00fcretmeye devam ediyor. 2010 y\u0131l\u0131nda 200 milyon dolarl\u0131k yat\u0131r\u0131m ile sekt\u00f6re g\u00fc\u00e7l\u00fc bir giri\u015f yapan Humanis, ba\u015fta kardiyoloji, dermatoloji, gastroenteroloji olmak \u00fczere bir\u00e7ok \u00f6nemli tedavi alan\u0131na y\u00f6nelik geni\u015f bir \u00fcr\u00fcn portf\u00f6y\u00fcne sahip. T\u00fcrkiye\u2019de Sanayi ve Teknoloji Bakanl\u0131\u011f\u0131 taraf\u0131ndan te\u015fvik edilen en b\u00fcy\u00fck 5 ila\u00e7 Ar-Ge merkezinden birine sahip olan \u015firket, yakla\u015f\u0131k 100 ki\u015fiden olu\u015fan g\u00fc\u00e7l\u00fc Ar-Ge ekibi ile birlikte sekt\u00f6rde g\u00fcvenilir ve yenilik\u00e7i sa\u011fl\u0131k \u00e7\u00f6z\u00fcmleri \u00fcretmek i\u00e7in \u00e7al\u0131\u015f\u0131yor. \u015eimdiye kadar 100\u2019den fazla molek\u00fclde e\u015fde\u011fer \u00fcr\u00fcn geli\u015ftiren Humanis, 2030 y\u0131l\u0131na kadar \u00fcr\u00fcn portf\u00f6y\u00fcn\u00fc geli\u015ftirerek merkezi sistemi, diyabet ve onkoloji alanlar\u0131na girmeyi hedefliyor. Yak\u0131n zamanda serebrotendin\u00f6z ksantomatozis hastal\u0131\u011f\u0131n\u0131n tedavisine y\u00f6nelik \u00fcr\u00fcn\u00fc ile nadir hastal\u0131klar alan\u0131na da ad\u0131m atan Humanis, bu alandaki yat\u0131r\u0131mlar\u0131n\u0131 ve Ar-Ge \u00e7al\u0131\u015fmalar\u0131n\u0131 h\u0131zland\u0131rd\u0131.<\/p>\n\n\n\n<p>Yenilik\u00e7i vizyonu ve g\u00fc\u00e7l\u00fc teknolojik alt yap\u0131s\u0131 ile Avrupa Birli\u011fi standartlar\u0131nda \u00fcretim yapan Humanis, serebrotendin\u00f6z ksantomatozis hastal\u0131\u011f\u0131n\u0131n tedavisine y\u00f6nelik sundu\u011fu ila\u00e7 ile 13. Alt\u0131n Havan \u00d6d\u00fclleri\u2019nde \u00f6nemli bir \u00f6d\u00fcle lay\u0131k g\u00f6r\u00fcld\u00fc. Humanis, T\u00fcrk ila\u00e7 ve eczac\u0131l\u0131k sekt\u00f6r\u00fcndeki \u00e7al\u0131\u015fmalar\u0131n \u00f6d\u00fcllendirildi\u011fi organizasyonda, nadir hastal\u0131klara y\u00f6nelik \u00fcretti\u011fi ilk ilac\u0131 ile \u2018\u00dcr\u00fcn \u00d6d\u00fcl\u00fc\u2019n\u00fc kazand\u0131.<\/p>\n\n\n\n<p><strong>Yunus Sancak: \u201c\u00dcr\u00fcn \u00d6d\u00fcl\u00fc Ald\u0131\u011f\u0131m\u0131z i\u00e7in Gururluyuz\u201d<\/strong><\/p>\n\n\n\n<p>Y\u00fczde 100 yerli sermayeli bir ila\u00e7 firmas\u0131 olarak, sekt\u00f6r\u00fcn \u00f6nemli bir ihtiyac\u0131n\u0131 kar\u015f\u0131lad\u0131klar\u0131 i\u00e7in mutlu olduklar\u0131n\u0131 belirten Humanis CEO\u2019su Yunus Sancak, \u00f6d\u00fclle ilgili \u015fu de\u011ferlendirmelerde bulundu:<\/p>\n\n\n\n<p>\u201cDeneyimini ve yat\u0131r\u0131m\u0131n\u0131 sa\u011fl\u0131kl\u0131 ve iyi ya\u015fam\u0131 desteklemek i\u00e7in kullanan bir ila\u00e7 firmas\u0131y\u0131z. Bu \u00e7abam\u0131z\u0131n Alt\u0131n Havan \u00d6d\u00fclleri\u2019nde \u2018\u00dcr\u00fcn \u00d6d\u00fcl\u00fc\u2019 ile takdir edilmesi bizim i\u00e7in gurur verici. Kanada ve Rusya\u2019dan GMP (\u0130yi \u00dcretim Uygulamalar\u0131) sertifikalar\u0131na, 2015 y\u0131l\u0131ndan itibaren ise Avrupa Birli\u011fi \u00fclkelerinde ge\u00e7erli olan EU GMP sertifikas\u0131na sahip bir firma olarak, QbD, EMA ve ICH reg\u00fclasyonlar\u0131na uyumlu \u015fekilde \u00fcr\u00fcn geli\u015ftirdi\u011fimiz Ar-Ge merkezimizde, di\u011fer alanlarda oldu\u011fu gibi nadir hastal\u0131klar gibi zorlu ve \u00f6zel alanlara y\u00f6nelik ihtiya\u00e7lar\u0131 kar\u015f\u0131lamak i\u00e7in de etkin ve g\u00fcvenilir \u00e7\u00f6z\u00fcmler \u00fcretmek i\u00e7in \u00e7al\u0131\u015fmalar\u0131m\u0131z\u0131 s\u00fcrd\u00fcr\u00fcyoruz.\u201d&nbsp;<\/p>\n\n\n\n<p><strong>Fatih Elay:: \u201c2024 Y\u0131l\u0131n\u0131 Umutla ve Heyecanla Kar\u015f\u0131l\u0131yoruz\u201d<\/strong><\/p>\n\n\n\n<p>2023 y\u0131l\u0131 sona ererken Humanis olarak bir\u00e7ok \u00f6nemli ad\u0131m att\u0131klar\u0131n\u0131 ifade eden Humanis Teknik Operasyonlar Genel M\u00fcd\u00fcr\u00fc Fatih Elay, \u00f6d\u00fcl\u00fcn \u00f6nemi ile ilgili \u015funlar\u0131 s\u00f6yledi: \u201c2010 y\u0131l\u0131ndan bu yana d\u00fczenlenen Alt\u0131n Havan organizasyonunu sekt\u00f6r\u00fcm\u00fcz i\u00e7in \u00e7ok de\u011ferli buluyorum. \u0130nsan odakl\u0131 bir firma olarak \u00fcretmek ve g\u00fcvenilir sa\u011fl\u0131k \u00e7\u00f6z\u00fcmlerimizi ihtiyac\u0131 olan herkese ula\u015ft\u0131rabilmek tutkusu ile \u00e7al\u0131\u015f\u0131yoruz. Bu tutkuyla y\u00fcr\u00fctt\u00fc\u011f\u00fcm\u00fcz faaliyetlerin Alt\u0131n Havan gibi bir organizasyon taraf\u0131ndan \u00f6d\u00fcllendirilmesi bizi \u00e7ok mutlu etti. serebrotendin\u00f6z ksantomatozis hastal\u0131\u011f\u0131n\u0131n tedavisine y\u00f6nelik bu \u00fcr\u00fcn\u00fc yerli \u00fcretim olarak pazara sunacak olmam\u0131z sebebiyle, kamuya fiyat avantaj\u0131 da sa\u011fl\u0131yoruz. Buna g\u00f6re 2024 y\u0131l\u0131nda, kamuya 250 milyon TL tasarruf katk\u0131s\u0131 yapaca\u011f\u0131m\u0131z\u0131 \u00f6ng\u00f6rmekteyiz. Humanis ve sekt\u00f6r\u00fcm\u00fcz ad\u0131na g\u00fc\u00e7l\u00fc ad\u0131mlarla 2023 y\u0131l\u0131n\u0131 bitirirken, b\u00f6yle de\u011ferli \u00f6d\u00fcller sayesinde 2024 y\u0131l\u0131n\u0131 umutla ve heyecanla kar\u015f\u0131l\u0131yoruz.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u0130nsan odakl\u0131 sa\u011fl\u0131k felsefesini benimseyen Humanis, 13. Alt\u0131n Havan \u00d6d\u00fclleri\u2019nde nadir hastal\u0131klardan biri olan serebrotendin\u00f6z ksantomatozisin tedavisine y\u00f6nelik sundu\u011fu \u00fcr\u00fcn\u00fc ile \u2018\u00dcr\u00fcn \u00d6d\u00fcl\u00fc\u2019ne l\u00e2y\u0131k g\u00f6r\u00fcld\u00fc.<\/p>\n","protected":false},"author":1,"featured_media":2571,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,3],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2568"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2568"}],"version-history":[{"count":2,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2568\/revisions"}],"predecessor-version":[{"id":2572,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/2568\/revisions\/2572"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/2571"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}